Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs.
about
Next-generation surveillance strategies for patients with lymphomaHodgkin lymphoma, version 2.2015.Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy.Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma.Beyond PET/CT in Hodgkin lymphoma: a comprehensive review of the role of imaging at initial presentation, during follow-up and for assessment of treatment-related complications.A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infection.Surveillance imaging in pediatric Hodgkin Lymphoma.Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.Current role of FDG PET/CT in lymphoma.Role of PET in lymphoma.PET-CT in Staging, Response Evaluation, and Surveillance of Lymphoma.Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma.Surveillance Scans in Lymphoma: Friend or Foe?No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.The role of FDG-PET in Hodgkin lymphomaPositron emission tomography/computed tomography surveillance in patients with lymphoma: a fox hunt?Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow-up for patients with no residual mass.Adding weight to a sinking ship: more reasons not to perform routine surveillance imaging in patients with diffuse large B-cell lymphoma in remission.PET/CT in the Evaluation of Relapsed or Refractory Hodgkin Lymphoma.Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remission.Children with sickle cell disease need more effective therapies, not more X-rays.Computed tomography and positron emission tomography/computed tomography surveillance after combined modality treatment of supradiaphragmatic Hodgkin lymphoma: a clinical and economic perspective.
P2860
Q28084956-A0C5A24A-164E-445D-A809-BB74FF72D353Q30769157-31E21891-09AD-4E9C-AD6F-AE85B6822DCAQ35036383-BFB8A864-6DB1-4012-98E3-5C19E763FDC2Q35103536-8BBB8916-9AE0-4CD6-B5C2-12BEE042DC46Q35650402-7B6BB00F-50CC-4817-9030-BA176F42A814Q36816955-723F23FC-E6E4-41BA-A8EF-595E9A33C85BQ37149757-97F40D14-8327-4F77-9F80-B371FBFE857CQ37614753-1EDCCC1B-896D-40DB-802D-387414D86207Q38119890-EC10B6DC-359F-41BB-8545-2BB35618757BQ38184954-C88A84D1-8A60-4160-BCAF-2B02B3DC4A8EQ38187365-C46FAB4B-8659-49DC-A9F3-C936501971A6Q38195220-80B8374D-A54C-4FAA-B1A3-83FAFF954992Q38794783-84FEBA12-3FF0-43B0-9F94-0932B7C8C515Q39036785-7468B40F-AE22-4F56-9B04-1E4F4413C684Q39142301-83355B6A-2664-4C96-8DFA-B734509E187DQ40929122-7C1C7C39-1E1C-4FFF-9E0E-B0AF54D6845DQ41691698-7C6B4ADA-D004-4DAD-BA98-38B9621117AAQ43188726-BB1CAC5B-86B5-4ADD-99F1-191EAE28E13BQ44611640-389B02AF-085D-4C4E-B9BE-ADE72CBC0F68Q47189782-DF2268E9-7A56-404C-AD37-74C0F0C8A4BBQ49764261-8AD58573-BDB0-4D18-BF04-F70F0E07E905Q52991555-0EB218C3-3A76-4026-BC02-3A18C2FFE50AQ53074495-FE331C6A-9A5E-4A2D-8155-598259AF6F5FQ53124289-E063BE7E-F710-433C-9DD2-0AA8648754E7
P2860
Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Positron emission tomography/c ...... edictive value and high costs.
@ast
Positron emission tomography/c ...... edictive value and high costs.
@en
type
label
Positron emission tomography/c ...... edictive value and high costs.
@ast
Positron emission tomography/c ...... edictive value and high costs.
@en
prefLabel
Positron emission tomography/c ...... edictive value and high costs.
@ast
Positron emission tomography/c ...... edictive value and high costs.
@en
P2093
P2860
P50
P1433
P1476
Positron emission tomography/c ...... redictive value and high costs
@en
P2093
Anne Lerberg Nielsen
Annika Loft
Ilse Christiansen
Karen Juul Mylam
Lars Munksgaard
Peter Brown
Victor Iyer
P2860
P304
P356
10.3324/HAEMATOL.2011.056010
P577
2011-12-29T00:00:00Z